Connect with us

Uncategorized

Biotechnology reagents market size to increase by USD 36,019.44 million; North America to account for 48% of market growth – Technavio

Biotechnology reagents market size to increase by USD 36,019.44 million; North America to account for 48% of market growth – Technavio
PR Newswire
NEW YORK, Jan. 24, 2023

NEW YORK, Jan. 24, 2023 /PRNewswire/ — The Biotechnology Reagents Market by …

Published

1 year ago

on

Biotechnology reagents market size to increase by USD 36,019.44 million; North America to account for 48% of market growth - Technavio

PR Newswire

NEW YORK, Jan. 24, 2023

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Biotechnology Reagents Market by Technology, Application, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 36,019.44 million between 2022 and 2027 at a CAGR of 7.51%. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report

Regional Analysis

By region, the global biotechnology reagents market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 48% of market growth during the forecast period. Factors such as ongoing research in biological sciences, investments by various biotechnology companies, and high demand for biotechnology reagents are driving the growth of the biotechnology reagents market in North America. Buy the report

Company Profiles

The biotechnology reagents market report includes information on the key products and recent developments of leading vendors, including:

  • Danaher Corp. - The company offers biotechnology reagents that are engineered to deliver reduced spillover to optimize resolution when used with other fluorochromes.
  • F. Hoffmann La Roche Ltd. - The company offers biotechnology reagents that include active ingredients for diagnostic assay which include nucleic acid isolation and purification, to enzymes for amplification and nucleotides.
  • Lonza Group Ltd. - The company offers biotechnology reagents that are required for the growth of Endothelial Cells.
  • Merck KGaA - The company offers biotechnology reagents that are subjected to stringent controls during development and production to ensure reliable and reproducible results.

Market Dynamics

The market is driven by factors such as the high usage of biotechnology reagents in diagnostic and therapeutic applications, increasing research and development investments by federal agencies and biotechnology firms, and the presence of high throughput and novel technologies. However, stringent regulations are hindering market growth.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

  • By technology, the market is segmented into chromatography, in-vitro diagnostics, polymerase chain reaction, cell culture, and others. The chromatography segment accounted for the largest share of the market in 2022.
  • By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America held the largest share of the market in 2022.

Related Reports:

  • The genomics market is estimated to grow at a CAGR of 10.53% between 2022 and 2027. The size of the market is forecast to increase by USD 18,244.34 million. The increasing demand for creating and upgrading genome databases is notably driving the market growth, although factors such as the shortage of skilled genetics professionals may impede the market growth.
  • The microbiomes market is estimated to grow at a CAGR of 21.95% between 2022 and 2027. The size of the market is forecast to increase by USD 891.94 million. The increasing prevalence of diseases is notably driving the market growth, although factors such as challenges related to manufacturing and formulation may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this biotechnology reagents market report?

  • CAGR of the market during the forecast period.
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the biotechnology reagents market and its contribution to the parent market.
  • Accurate predictions about upcoming trends and changes in consumer behavior.
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW).
  • A thorough analysis of the market's competitive landscape and detailed information about vendors.
  • Comprehensive analysis of factors that will challenge the growth of biotechnology reagents market vendors. 

Biotechnology Reagents Market Scope

Report Coverage

Details

Page number

180

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.51%

Market growth 2023-2027

USD 36,019.44 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

6.89

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 48%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., Illumina Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., New England Biolabs Inc., PerkinElmer Inc., Promega Corp., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Waters Corp., and Tosoh Corp.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global biotechnology reagents market 2017 - 2021
    • Exhibit 18: Historic Market Size – Data Table on Global biotechnology reagents market 2017 - 2021 ($ million)
  • 4.2 Technology Segment Analysis 2017 - 2021
    • Exhibit 19: Historic Market Size – Technology Segment 2017 - 2021 ($ million)
  • 4.3 Application Segment Analysis 2017 - 2021
    • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary 
    • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry 
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition 
    • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technology

  • 6.1 Market segments 
    • Exhibit 30: Chart on Technology - Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Technology - Market share 2022-2027 (%)
  • 6.2 Comparison by Technology 
    • Exhibit 32: Chart on Comparison by Technology
    • Exhibit 33: Data Table on Comparison by Technology
  • 6.3 Chromatography - Market size and forecast 2022-2027
    • Exhibit 34: Chart on Chromatography - Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Chromatography - Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Chromatography - Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Chromatography - Year-over-year growth 2022-2027 (%)
  • 6.4 In-vitro diagnostics - Market size and forecast 2022-2027
    • Exhibit 38: Chart on In-vitro diagnostics - Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on In-vitro diagnostics - Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on In-vitro diagnostics - Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on In-vitro diagnostics - Year-over-year growth 2022-2027 (%)
  • 6.5 Polymerase chain reaction - Market size and forecast 2022-2027 
    • Exhibit 42: Chart on Polymerase chain reaction - Market size and forecast 2022-2027 ($ million)
    • Exhibit 43: Data Table on Polymerase chain reaction - Market size and forecast 2022-2027 ($ million)
    • Exhibit 44: Chart on Polymerase chain reaction - Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Polymerase chain reaction - Year-over-year growth 2022-2027 (%)
  • 6.6 Cell culture - Market size and forecast 2022-2027
    • Exhibit 46: Chart on Cell culture - Market size and forecast 2022-2027 ($ million)
    • Exhibit 47: Data Table on Cell culture - Market size and forecast 2022-2027 ($ million)
    • Exhibit 48: Chart on Cell culture - Year-over-year growth 2022-2027 (%)
    • Exhibit 49: Data Table on Cell culture - Year-over-year growth 2022-2027 (%)
  • 6.7 Others - Market size and forecast 2022-2027
    • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
    • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.8 Market opportunity by Technology 
    • Exhibit 54: Market opportunity by Technology ($ million)

7 Market Segmentation by Application

  • 7.1 Market segments 
    • Exhibit 55: Chart on Application - Market share 2022-2027 (%)
    • Exhibit 56: Data Table on Application - Market share 2022-2027 (%)
  • 7.2 Comparison by Application 
    • Exhibit 57: Chart on Comparison by Application
    • Exhibit 58: Data Table on Comparison by Application
  • 7.3 Protein synthesis and purification - Market size and forecast 2022-2027 
    • Exhibit 59: Chart on Protein synthesis and purification - Market size and forecast 2022-2027 ($ million)
    • Exhibit 60: Data Table on Protein synthesis and purification - Market size and forecast 2022-2027 ($ million)
    • Exhibit 61: Chart on Protein synthesis and purification - Year-over-year growth 2022-2027 (%)
    • Exhibit 62: Data Table on Protein synthesis and purification - Year-over-year growth 2022-2027 (%)
  • 7.4 Gene expression - Market size and forecast 2022-2027
    • Exhibit 63: Chart on Gene expression - Market size and forecast 2022-2027 ($ million)
    • Exhibit 64: Data Table on Gene expression - Market size and forecast 2022-2027 ($ million)
    • Exhibit 65: Chart on Gene expression - Year-over-year growth 2022-2027 (%)
    • Exhibit 66: Data Table on Gene expression - Year-over-year growth 2022-2027 (%)
  • 7.5 DNA and RNA analysis - Market size and forecast 2022-2027
    • Exhibit 67: Chart on DNA and RNA analysis - Market size and forecast 2022-2027 ($ million)
    • Exhibit 68: Data Table on DNA and RNA analysis - Market size and forecast 2022-2027 ($ million)
    • Exhibit 69: Chart on DNA and RNA analysis - Year-over-year growth 2022-2027 (%)
    • Exhibit 70: Data Table on DNA and RNA analysis - Year-over-year growth 2022-2027 (%)
  • 7.6 Drug testing - Market size and forecast 2022-2027
    • Exhibit 71: Chart on Drug testing - Market size and forecast 2022-2027 ($ million)
    • Exhibit 72: Data Table on Drug testing - Market size and forecast 2022-2027 ($ million)
    • Exhibit 73: Chart on Drug testing - Year-over-year growth 2022-2027 (%)
    • Exhibit 74: Data Table on Drug testing - Year-over-year growth 2022-2027 (%)
  • 7.7 Market opportunity by Application 
    • Exhibit 75: Market opportunity by Application ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 77: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 78: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 79: Chart on Geographic comparison
    • Exhibit 80: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
    • Exhibit 81: Chart on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on North America - Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
    • Exhibit 85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on Europe - Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
    • Exhibit 89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on Asia - Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
    • Exhibit 93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
    • Exhibit 97: Chart on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on US - Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
    • Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
    • Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
    • Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 France - Market size and forecast 2022-2027
    • Exhibit 109: Chart on France - Market size and forecast 2022-2027 ($ million)
    • Exhibit 110: Data Table on France - Market size and forecast 2022-2027 ($ million)
    • Exhibit 111: Chart on France - Year-over-year growth 2022-2027 (%)
    • Exhibit 112: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
    • Exhibit 113: Chart on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 114: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 115: Chart on Japan - Year-over-year growth 2022-2027 (%)
    • Exhibit 116: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography 
    • Exhibit 117: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 118: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape 
    • Exhibit 119: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption 
    • Exhibit 120: Overview on factors of disruption
  • 11.4 Industry risks 
    • Exhibit 121: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered 
    • Exhibit 122: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 123: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories 
    • Exhibit 124: Abbott Laboratories - Overview
    • Exhibit 125: Abbott Laboratories - Business segments
    • Exhibit 126: Abbott Laboratories - Key news
    • Exhibit 127: Abbott Laboratories - Key offerings
    • Exhibit 128: Abbott Laboratories - Segment focus
  • 12.4 Agilent Technologies Inc. 
    • Exhibit 129: Agilent Technologies Inc. - Overview
    • Exhibit 130: Agilent Technologies Inc. - Business segments
    • Exhibit 131: Agilent Technologies Inc. - Key news
    • Exhibit 132: Agilent Technologies Inc. - Key offerings
    • Exhibit 133: Agilent Technologies Inc. - Segment focus
  • 12.5 Becton Dickinson and Co. 
    • Exhibit 134: Becton Dickinson and Co. - Overview
    • Exhibit 135: Becton Dickinson and Co. - Business segments
    • Exhibit 136: Becton Dickinson and Co. - Key news
    • Exhibit 137: Becton Dickinson and Co. - Key offerings
    • Exhibit 138: Becton Dickinson and Co. - Segment focus
  • 12.6 Bio Rad Laboratories Inc. 
    • Exhibit 139: Bio Rad Laboratories Inc. - Overview
    • Exhibit 140: Bio Rad Laboratories Inc. - Business segments
    • Exhibit 141: Bio Rad Laboratories Inc. - Key news
    • Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
    • Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
  • 12.7 bioMerieux SA 
    • Exhibit 144: bioMerieux SA - Overview
    • Exhibit 145: bioMerieux SA - Product / Service
    • Exhibit 146: bioMerieux SA - Key offerings
  • 12.8 Danaher Corp. 
    • Exhibit 147: Danaher Corp. - Overview
    • Exhibit 148: Danaher Corp. - Business segments
    • Exhibit 149: Danaher Corp. - Key news
    • Exhibit 150: Danaher Corp. - Key offerings
    • Exhibit 151: Danaher Corp. - Segment focus
  • 12.9 F. Hoffmann La Roche Ltd. 
    • Exhibit 152: F. Hoffmann La Roche Ltd. - Overview
    • Exhibit 153: F. Hoffmann La Roche Ltd. - Business segments
    • Exhibit 154: F. Hoffmann La Roche Ltd. - Key news
    • Exhibit 155: F. Hoffmann La Roche Ltd. - Key offerings
    • Exhibit 156: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.10 Lonza Group Ltd. 
    • Exhibit 157: Lonza Group Ltd. - Overview
    • Exhibit 158: Lonza Group Ltd. - Business segments
    • Exhibit 159: Lonza Group Ltd. - Key news
    • Exhibit 160: Lonza Group Ltd. - Key offerings
    • Exhibit 161: Lonza Group Ltd. - Segment focus
  • 12.11 Merck KGaA 
    • Exhibit 162: Merck KGaA - Overview
    • Exhibit 163: Merck KGaA - Business segments
    • Exhibit 164: Merck KGaA - Key news
    • Exhibit 165: Merck KGaA - Key offerings
    • Exhibit 166: Merck KGaA - Segment focus
  • 12.12 Meridian Bioscience Inc. 
    • Exhibit 167: Meridian Bioscience Inc. - Overview
    • Exhibit 168: Meridian Bioscience Inc. - Business segments
    • Exhibit 169: Meridian Bioscience Inc. - Key offerings
    • Exhibit 170: Meridian Bioscience Inc. - Segment focus
  • 12.13 PerkinElmer Inc. 
    • Exhibit 171: PerkinElmer Inc. - Overview
    • Exhibit 172: PerkinElmer Inc. - Business segments
    • Exhibit 173: PerkinElmer Inc. - Key news
    • Exhibit 174: PerkinElmer Inc. - Key offerings
    • Exhibit 175: PerkinElmer Inc. - Segment focus
  • 12.14 Promega Corp. 
    • Exhibit 176: Promega Corp. - Overview
    • Exhibit 177: Promega Corp. - Product / Service
    • Exhibit 178: Promega Corp. - Key offerings
  • 12.15 Siemens AG 
    • Exhibit 179: Siemens AG - Overview
    • Exhibit 180: Siemens AG - Business segments
    • Exhibit 181: Siemens AG - Key news
    • Exhibit 182: Siemens AG - Key offerings
    • Exhibit 183: Siemens AG - Segment focus
  • 12.16 Sysmex Corp. 
    • Exhibit 184: Sysmex Corp. - Overview
    • Exhibit 185: Sysmex Corp. - Business segments
    • Exhibit 186: Sysmex Corp. - Key offerings
    • Exhibit 187: Sysmex Corp. - Segment focus
  • 12.17 Thermo Fisher Scientific Inc. 
    • Exhibit 188: Thermo Fisher Scientific Inc. - Overview
    • Exhibit 189: Thermo Fisher Scientific Inc. - Business segments
    • Exhibit 190: Thermo Fisher Scientific Inc. - Key news
    • Exhibit 191: Thermo Fisher Scientific Inc. - Key offerings
    • Exhibit 192: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 193: Inclusions checklist
    • Exhibit 194: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 195: Currency conversion rates for US$
  • 13.4 Research methodology 
    • Exhibit 196: Research methodology
    • Exhibit 197: Validation techniques employed for market sizing
    • Exhibit 198: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 199: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/biotechnology-reagents-market-size-to-increase-by-usd-36-019-44-million-north-america-to-account-for-48-of-market-growth---technavio-301727948.html

SOURCE Technavio

Read More

Related Topics:
Continue Reading

Uncategorized

Aging at AACR Annual Meeting 2024

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging…

Published

10 hours ago

on

March 11, 2024

By

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals. 

Credit: Impact Journals

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals. 

Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling Progress • Revolutionizing Care.”

Visit booth #4159 at the AACR Annual Meeting 2024 to connect with members of the Aging team.

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed and archived by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Aging X
  • Aging Facebook
  • Aging Instagram
  • Aging YouTube
  • Aging LinkedIn
  • Aging SoundCloud
  • Aging Pinterest
  • Aging Reddit

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

Read More

Continue Reading

Uncategorized

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked…

Published

14 hours ago

on

March 11, 2024

By

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked by the NY Fed Consumer Survey extended their late 2023 slide, with 3Y inflation expectations in January sliding to a record low 2.4% (from 2.6% in December), even as 1 and 5Y inflation forecasts remained flat, moments ago the NY Fed reported that in February there was a sharp rebound in longer-term inflation expectations, rising to 2.7% from 2.4% at the three-year ahead horizon, and jumping to 2.9% from 2.5% at the five-year ahead horizon, while the 1Y inflation outlook was flat for the 3rd month in a row, stuck at 3.0%. 

The increases in both the three-year ahead and five-year ahead measures were most pronounced for respondents with at most high school degrees (in other words, the "really smart folks" are expecting deflation soon). The survey’s measure of disagreement across respondents (the difference between the 75th and 25th percentile of inflation expectations) decreased at all horizons, while the median inflation uncertainty—or the uncertainty expressed regarding future inflation outcomes—declined at the one- and three-year ahead horizons and remained unchanged at the five-year ahead horizon.

Going down the survey, we find that the median year-ahead expected price changes increased by 0.1 percentage point to 4.3% for gas; decreased by 1.8 percentage points to 6.8% for the cost of medical care (its lowest reading since September 2020); decreased by 0.1 percentage point to 5.8% for the cost of a college education; and surprisingly decreased by 0.3 percentage point for rent to 6.1% (its lowest reading since December 2020), and remained flat for food at 4.9%.

We find the rent expectations surprising because it is happening just asking rents are rising across the country.

At the same time as consumers erroneously saw sharply lower rents, median home price growth expectations remained unchanged for the fifth consecutive month at 3.0%.

Turning to the labor market, the survey found that the average perceived likelihood of voluntary and involuntary job separations increased, while the perceived likelihood of finding a job (in the event of a job loss) declined. "The mean probability of leaving one’s job voluntarily in the next 12 months also increased, by 1.8 percentage points to 19.5%."

Mean unemployment expectations - or the mean probability that the U.S. unemployment rate will be higher one year from now - decreased by 1.1 percentage points to 36.1%, the lowest reading since February 2022. Additionally, the median one-year-ahead expected earnings growth was unchanged at 2.8%, remaining slightly below its 12-month trailing average of 2.9%.

Turning to household finance, we find the following:

  • The median expected growth in household income remained unchanged at 3.1%. The series has been moving within a narrow range of 2.9% to 3.3% since January 2023, and remains above the February 2020 pre-pandemic level of 2.7%.
  • Median household spending growth expectations increased by 0.2 percentage point to 5.2%. The increase was driven by respondents with a high school degree or less.
  • Median year-ahead expected growth in government debt increased to 9.3% from 8.9%.
  • The mean perceived probability that the average interest rate on saving accounts will be higher in 12 months increased by 0.6 percentage point to 26.1%, remaining below its 12-month trailing average of 30%.
  • Perceptions about households’ current financial situations deteriorated somewhat with fewer respondents reporting being better off than a year ago. Year-ahead expectations also deteriorated marginally with a smaller share of respondents expecting to be better off and a slightly larger share of respondents expecting to be worse off a year from now.
  • The mean perceived probability that U.S. stock prices will be higher 12 months from now increased by 1.4 percentage point to 38.9%.
  • At the same time, perceptions and expectations about credit access turned less optimistic: "Perceptions of credit access compared to a year ago deteriorated with a larger share of respondents reporting tighter conditions and a smaller share reporting looser conditions compared to a year ago."

Also, a smaller percentage of consumers, 11.45% vs 12.14% in prior month, expect to not be able to make minimum debt payment over the next three months

Last, and perhaps most humorous, is the now traditional cognitive dissonance one observes with these polls, because at a time when long-term inflation expectations jumped, which clearly suggests that financial conditions will need to be tightened, the number of respondents expecting higher stock prices one year from today jumped to the highest since November 2021... which incidentally is just when the market topped out during the last cycle before suffering a painful bear market.

Tyler Durden Mon, 03/11/2024 - 12:40

Read More

Continue Reading

Uncategorized

Homes listed for sale in early June sell for $7,700 more

New Zillow research suggests the spring home shopping season may see a second wave this summer if mortgage rates fall
The post Homes listed for sale in…

Published

22 hours ago

on

March 11, 2024

By

  • A Zillow analysis of 2023 home sales finds homes listed in the first two weeks of June sold for 2.3% more. 
  • The best time to list a home for sale is a month later than it was in 2019, likely driven by mortgage rates.
  • The best time to list can be as early as the second half of February in San Francisco, and as late as the first half of July in New York and Philadelphia. 

Spring home sellers looking to maximize their sale price may want to wait it out and list their home for sale in the first half of June. A new Zillow® analysis of 2023 sales found that homes listed in the first two weeks of June sold for 2.3% more, a $7,700 boost on a typical U.S. home.  

The best time to list consistently had been early May in the years leading up to the pandemic. The shift to June suggests mortgage rates are strongly influencing demand on top of the usual seasonality that brings buyers to the market in the spring. This home-shopping season is poised to follow a similar pattern as that in 2023, with the potential for a second wave if the Federal Reserve lowers interest rates midyear or later. 

The 2.3% sale price premium registered last June followed the first spring in more than 15 years with mortgage rates over 6% on a 30-year fixed-rate loan. The high rates put home buyers on the back foot, and as rates continued upward through May, they were still reassessing and less likely to bid boldly. In June, however, rates pulled back a little from 6.79% to 6.67%, which likely presented an opportunity for determined buyers heading into summer. More buyers understood their market position and could afford to transact, boosting competition and sale prices.

The old logic was that sellers could earn a premium by listing in late spring, when search activity hit its peak. Now, with persistently low inventory, mortgage rate fluctuations make their own seasonality. First-time home buyers who are on the edge of qualifying for a home loan may dip in and out of the market, depending on what’s happening with rates. It is almost certain the Federal Reserve will push back any interest-rate cuts to mid-2024 at the earliest. If mortgage rates follow, that could bring another surge of buyers later this year.

Mortgage rates have been impacting affordability and sale prices since they began rising rapidly two years ago. In 2022, sellers nationwide saw the highest sale premium when they listed their home in late March, right before rates barreled past 5% and continued climbing. 

Zillow’s research finds the best time to list can vary widely by metropolitan area. In 2023, it was as early as the second half of February in San Francisco, and as late as the first half of July in New York. Thirty of the top 35 largest metro areas saw for-sale listings command the highest sale prices between May and early July last year. 

Zillow also found a wide range in the sale price premiums associated with homes listed during those peak periods. At the hottest time of the year in San Jose, homes sold for 5.5% more, a $88,000 boost on a typical home. Meanwhile, homes in San Antonio sold for 1.9% more during that same time period.  

 

Metropolitan Area Best Time to List Price Premium Dollar Boost
United States First half of June 2.3% $7,700
New York, NY First half of July 2.4% $15,500
Los Angeles, CA First half of May 4.1% $39,300
Chicago, IL First half of June 2.8% $8,800
Dallas, TX First half of June 2.5% $9,200
Houston, TX Second half of April 2.0% $6,200
Washington, DC Second half of June 2.2% $12,700
Philadelphia, PA First half of July 2.4% $8,200
Miami, FL First half of June 2.3% $12,900
Atlanta, GA Second half of June 2.3% $8,700
Boston, MA Second half of May 3.5% $23,600
Phoenix, AZ First half of June 3.2% $14,700
San Francisco, CA Second half of February 4.2% $50,300
Riverside, CA First half of May 2.7% $15,600
Detroit, MI First half of July 3.3% $7,900
Seattle, WA First half of June 4.3% $31,500
Minneapolis, MN Second half of May 3.7% $13,400
San Diego, CA Second half of April 3.1% $29,600
Tampa, FL Second half of June 2.1% $8,000
Denver, CO Second half of May 2.9% $16,900
Baltimore, MD First half of July 2.2% $8,200
St. Louis, MO First half of June 2.9% $7,000
Orlando, FL First half of June 2.2% $8,700
Charlotte, NC Second half of May 3.0% $11,000
San Antonio, TX First half of June 1.9% $5,400
Portland, OR Second half of April 2.6% $14,300
Sacramento, CA First half of June 3.2% $17,900
Pittsburgh, PA Second half of June 2.3% $4,700
Cincinnati, OH Second half of April 2.7% $7,500
Austin, TX Second half of May 2.8% $12,600
Las Vegas, NV First half of June 3.4% $14,600
Kansas City, MO Second half of May 2.5% $7,300
Columbus, OH Second half of June 3.3% $10,400
Indianapolis, IN First half of July 3.0% $8,100
Cleveland, OH First half of July  3.4% $7,400
San Jose, CA First half of June 5.5% $88,400

 

The post Homes listed for sale in early June sell for $7,700 more appeared first on Zillow Research.

Read More

Continue Reading

Trending